Jubilant Pharmova Ltd (JPL) delivered a growth of 3% q-o-q (quarter-on-quarter) in revenue in Q1FY21-22 due to gradual recovery in all segments. Operating profit remained flat q-o-q at Rs375 crore with operating margins at 23%, as against 24% in Q4FY20-21. Net profit grew marginally by 1% q-o-q to Rs170 crore with net profit margins dipping to 10% in Q1FY21-22.
This is a premium article. Your annual or monthly subscription will not give you access if it is outside your subscription period. You can buy it individually
Pay Per Article
Gift An Article
Yearly Digital Access
Monthly Digital Access
Access will cover your subscription period. Archives not included. Articles outside the subscription period can be bought individually.
Already a subscriber ? Log in